Bashar Abuqayas

Bashar Abuqayas, MD, is a Clinical Assistant Professor in the Department of Internal Medicine – Hospital Medicine at the University of Iowa, Carver College of Medicine. He is actively engaged in clinical practice and research, focusing on oncology, immunotherapy, and end-of-life cancer care.

Research Interests: His work spans several key areas including immune-related adverse events in cancer immunotherapy, outcomes of PD-1/PD-L1 inhibitors, palliative and supportive care in oncology, and the management of renal cell carcinoma. He contributes to both clinical databases and translational research initiatives.

The recent publications highlight a consistent focus on cancer immunotherapy, particularly in renal cell carcinoma and treatment-related complications. Themes across his work include patient-centered outcomes, safety of targeted therapies, and quality of end-of-life care in diverse healthcare settings.

Scientific Contributions:

• Co-developer of the REFINE database linking clinical and genomic data in renal cell carcinoma.
• Contributor to multi-institutional studies on cabozantinib for brain metastases.
• Researcher in cross-cultural validation of quality-of-life instruments in Jordan.

Advising and Grants: While no formal advisees or grant funding are mentioned in the current text, Dr. Abuqayas participates in collaborative research projects involving large datasets and international teams. His involvement in clinical trials and database development suggests engagement with research infrastructure and potential grant-supported work.

Labs and Teams: Dr. Abuqayas is affiliated with clinical and research teams at the University of Iowa and previously at King Hussein Cancer Center in Jordan. His work on the REFINE database indicates participation in bioinformatics and precision oncology research groups.